Meanwhile, our in-depth study clarified that both miR-136-5p and miR-198 negatively regulated the TFAP2C expression in HER2-Positive Breast Cancer cell lines, which was similar to the previous conclusions [36, 37]. Here, ERBB2 is linked to breast carcinoma.